文献速递慢病管理预防保健、筛查与疫苗基层心理健康

新冠疫情前后英格兰19种长期疾病新诊断记录的时间趋势:基于OpenSAFELY的人群队列研究

Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY.
PubMed 文献 · BMJ · 2026-01-21

结果显示疫情第一年所有19种疾病新诊断均急剧下降,此后恢复程度不一;截至2024年11月,抑郁、哮喘、COPD、银屑病和骨质疏松的累计诊断数仍低于预期,而慢性肾病诊断数在疫情恢复期较预期增加34.8%。按 ethnicity 和 socioeconomic status 分层的未调整分析提示痴呆诊断恢复模式存在差异。

要点

  • 疫情第一年19种长期疾病新诊断率均急剧下降,此后恢复程度因疾病而异。
  • 截至2024年11月,抑郁、哮喘、COPD、银屑病和骨质疏松的累计诊断数仍显著低于预期。

核心结论

  • 新冠疫情后抑郁、哮喘、COPD和骨质疏松等疾病的新诊断数持续低于预期,而慢性肾病诊断数自2022年起快速增加。
  • 按 ethnicity 和 socioeconomic status 分层的未调整分析提示痴呆诊断恢复模式存在差异。

研究设计与样本

  • 基于人群的队列研究,使用英格兰初级保健和住院数据,经NHS England批准。
  • 分析2016年4月1日至2024年11月30日19种长期疾病的年龄和性别标准化发病率和患病率趋势。
  • 使用季节性自回归积分滑动平均模型,基于疫情前模式预测预期诊断率,比较疫情后观察值与预期值的差异。

主要发现

  • 所有19种疾病在疫情第一年新诊断记录均急剧下降,随后恢复程度不一。

临床怎么用

  • 全科医生应关注抑郁、哮喘、COPD、银屑病和骨质疏松等疾病在疫情期间可能漏诊的累积病例,加强主动病例发现。
  • 对慢性肾病诊断数快速增加的现象保持警觉,结合临床评估避免过度诊断或确认真实发病增加。
  • 利用常规收集的健康数据进行近实时疾病监测,有助于发现诊断不足和医疗不公平。

局限性

  • 按 ethnicity 和 socioeconomic status 分层的分析为未调整分析,结果需谨慎解读。
  • 研究基于英格兰常规数据,结论外推至其他医疗体系时需考虑差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate temporal changes in rates of newly recorded diagnoses for 19 long term conditions in England in relation to the covid-19 pandemic by disease, age group, sex, socioeconomic status, and ethnicity. DESIGN: Population based cohort study. SETTING: Primary care and hospital admission data, with the approval of NHS England. PARTICIPANTS: 29 995 025 individuals registered with general practices in England contributing data to the OpenSAFELY-TPP platform. MAIN OUTCOME MEASURES: Temporal trends in age and sex standardised incident and prevalent diagnosis rates for 19 long term conditions between 1 April 2016 and 30 November 2024. Differences between expected and observed diagnosis rates after the onset of the covid-19 pandemic were compared using seasonal autoregressive integrated moving-average models, based on modelled projections of expected rates from pre-pandemic patterns. RESULTS: All 19 conditions showed a sharp decline in newly recorded diagnoses during the first year of the pandemic, followed by variable recovery. As of November 2024, cumulative reductions in diagnoses remained evident for conditions such as depression (734 800 (27.7%) fewer diagnoses than expected; 95% prediction interval (PI) 703 100 to 766 400), asthma (152 900 (16.4%) fewer diagnoses; 95% PI 137 500 to 168 300), chronic obstructive pulmonary disease (COPD) (90 100 (15.8%) fewer diagnoses; 95% PI 81 400 to 98 900), psoriasis (54 700 (17.1%) fewer diagnoses; 95% PI 50 100 to 59 200), and osteoporosis (54 100 (11.5%) fewer diagnoses; 95% PI 47 100 to 61 100). Conversely, diagnoses of chronic kidney disease have increased by 34.8% above expected levels during the pandemic recovery period, corresponding to 359 000 additional diagnoses (95% PI 333 500 to 384 500). Unadjusted subgroup analyses stratified by ethnicity and socioeconomic status indicated that, after an initial decrease, dementia diagnosis rates have risen above pre-pandemic levels for people of white ethnicity and in less deprived socioeconomic areas, but not for those from other ethnicities and more deprived areas. CONCLUSIONS: Since the covid-19 pandemic, there have been fewer diagnoses than expected for conditions such as depression, asthma, COPD, and osteoporosis, in contrast with a rapid increase in diagnoses of chronic kidney disease since 2022. Unadjusted analyses stratified by ethnicity and socioeconomic status suggest differential patterns of recovery, particularly for individuals with dementia. This study highlights the potential for near real time monitoring of disease epidemiology using routinely collected health data, informing strategies to enhance case detection and investigate inequities in healthcare.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Russell MD, Schaffer A, Bechman K, et al. Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY. BMJ. 2026. PMID: 41565343. doi:10.1136/bmj-2025-086393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。